Screening for testosterone abuse in male athletes using the measurement of urinary LH, a revision of the paradigm

Drug Testing and Analysis

Volumn 1, Issue 11-12, 2009, Pages 511-517

  Goebel, Catrin ^a   Howe, Christopher J ^a   Ho, Ken K ^a   Nelson, Anne ^a   Kazlauskas, Rymantas ^a   Trout, Graham J ^a  

^a NATIONAL MEASUREMENT INSTITUTE   (Australia)

Author keywords

Anabolic steroids; Luteinizing hormone; Sports medicine; T E ratio

Indexed keywords

DIAGNOSIS; LIPIDS;

ANABOLIC STEROID; E VALUES; ENDOGENOUS STEROIDS; LUTEINIZING HORMONES; MEASUREMENTS OF; PRIMARY SCREENING; SCREENING METHODS; T/E RATIO; TESTOSTERONE; WORLD ANTI-DOPING AGENCY;

BODY FLUIDS;

EPITESTOSTERONE; HUMAN GROWTH HORMONE; LUTEINIZING HORMONE; PLACEBO; TESTOSTERONE; TESTOSTERONE ESTER;

ADULT; ARTICLE; ATHLETE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPING; DOUBLE BLIND PROCEDURE; DRUG ABUSE; HORMONE URINE LEVEL; HUMAN; IMMUNOASSAY; LUTEINIZING HORMONE URINE LEVEL; MALE; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; TESTOSTERONE ABUSE;

EID: 77953440669     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.71     Document Type: Article

References (32)

1. M. Donike, J. Zimmermann, K. R. Barwald, W. Schanzer, V. Christ, K. Klostermann, G. Opfermann, Deutsche Zeit. Sportmed. 1984, 35, 14.
2. M. Donike, S. Rauth, A. Wolansky, in Proceedings of 10th Cologne Workshop on Dope Analysis, (Eds: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth), Sport und Buch Strauss: Koln, 1993, pp. 69.
3. J. Baenziger, L. Bowers, in Recent Advances in Doping Analysis (Eds: M. Donike, H. Geyer, A. Gotzmann, U. Mareck-Engelke, S. Rauth), Sport und Buch Strauss: Koln, 1994, pp 41.
4. D. H. Catlin, C. K. Hatton, Adv. Intern. Med. 1991, 36, 399.
5. C. H. Shackleton, A. Phillips, T. Chang, Y. Li, Steroids 1997, 62, 379.
6. X. De la Torre, J. Segura, Z. Yang, Y. Li, M.Wu, in Recent Advances in Doping Analysis (4) (Eds: W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke), Sport und Buch Strauss: Koln, 1997, pp. 71.
7. G. J. Trout, S. Soo, K. Kelly, in Recent Advances in Doping Analysis (10) (Eds: W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck), Sport und Buch Strauss: Koln, 2002, pp. 261.
8. WADA 2004, Adverse Analytical Findings Reported by Accredited Laboratories, www.wada-ama.org/rtecontent/document/ LABSTATS 2004.pdf, accessed 21 November 2009.
9. WADA 2005, Adverse Analytical Findings Reported by Accredited Laboratories, www.wada-ama.org/rtecontent/document/ LABSTATS 2005.pdf, accessed 21 November 2009.
10. H. Geyer, U. Flenker, U. Mareck, P. Platen, T. Piper, A. Schmechel, Y. Schrader, M. Thevis, W. Schanzer, in Recent Advances in Doping Analysis (15) (Eds: W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck), Sport und Buch Strauss: Koln, 2007, pp. 133.
11. L. D. Bowers, J. Clin. Endrocrin. Metab. 2008, 93, 2469.
12. R. Brooks, G. Jeremiah, W. Webb, M.Wheeler, J. Steroid. Biochem. 1979, 11, 913.
13. A. T. Kicman, R. V. Brooks, S. C. Collyer, D. A. Cowan, N. M. Nanjee, G. J. Southan, M. J. Wheeler, Br. J. SportsMed. 1990, 24, 253.
14. D. A. Cowan, A. T. Kicman, C. J. Walker, M. J. Wheeler, J. Endocrinol. 1991, 131, 147.
15. A. T. Kicman, D. A. Cowan, Br. Med. Bull. 1992, 48, 496.
16. P. J. Perry, J.H. MacIndoe, W. R. Yates, S. D. Scott, T. L.Holman, Clin. Chem. 1997, 43, 731.
17. A. E. Nelson, U. Meinhardt, J. L. Hansel, I. H. Walker, G. Stone, C. J. Howe, K. Leung, M. J. Seibel, R. C. Baxter, D. J. Handelsman, R. Kazlauskas, K. Ho, J. Clin. Endocrinol. Metab. 2008, 93, 2213.
18. G. J. Trout, R. Kazlauskas, Chem. Soc. Rev. 2004, 33, 1.
19. D. L. Heavner, W. T. Morgan, S. B. Sears, J. D. Richardson, G. D. Byrd, M. W. Ogden, J. Pharm. Biomed. Anal. 2006, 40, 928.
20. L. Dehennin, A. M. Matsumoto, J. Steroid Biochem. Mol. Biol. 1993, 44, 179.
21. E. Palonek, C. Gottlieb, M. Garle, I. Bjorkhem, K. Carlstrom, J. Steroid Biochem. Molec. Biol. 1995, 55, 121.
22. WADA 2009, Prohibited List, www.wada-ama.org/rtecontent/ document/2009 Prohibited List ENG Final 20 Sept 08.pdf, accessed 21 November 2009.
23. J. Jakobsson, L. Ekstrom, N. Inotsume, M. Garle, M. Lorentzon, C. Ohlsson, H.-K. Roh,K. Carlström, A. Rane, J. Clin. Endocrinol. Metab. 2006, 91, 687.
24. WADA Technical Document - TD2004 EAAS. Reporting and evaluation guidance for testosterone, epitestosterone, T/E ratio and other endogenous steroids, www.wada-ama.org/rtecontent/ document/end steroids aug 04.pdf, accessed 21 November 2009.
25. J. Jakobsson Schulze, J. Lundmark, M. Garle, I. Skilving, L. Ekstrom, A. Rane, J. Clin. Endocrinol. Metab. 2008, 93, 2500.
26. M. Garle, R. Ocka, E. Palonek, I. Bjorkhem, J. Chromatogr. B Biomed. Appl. 1996, 687, 55.
27. N. Robinson, C. Saudan, P. E. Sottas, P. Mangin, M. Saugy, J. Pharm. Biomed. Anal. 2007, 43, 270.
28. S. Voss, A. Gotzmann, H. Geyer, U. Mareck, W. Schanzer, in Recent Advances in Doping Analysis (13) (Eds: W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck), Sport und Buch Strauss: Koln, 2005, pp. 423.
29. D. J. Handelsman, C. Goebel, A. Idan, M. Jimenez, G. Trout, R. Kazlauskas, Clin. Endocrinol. 2009, 71, 417.
30. R. Kazlauskas, in Recent Advances in Doping Analysis (13) (Eds: W. Schanzer, H. Geyer, A. Gotzmann, U. Mareck), Sport und Buch Strauss: Koln, 2005, pp. 137.
31. D. Mataija-Botelho, P. Murphy, D. M. Pinto, D. L.MacLellan, C. Langlois A. A. Doucette, Proteomics Clin. Appl. 2009, 3, 95.
32. M. Lonnberg, M. Drevin, J. Carlsson, J. Immun. Methods 2008, 339, 236.